Literature DB >> 10568169

Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy.

Z J Wang1, Y Y He, C G Huang, J S Huang, Y C Huang, J Y An, Y Gu, L J Jiang.   

Abstract

Hypocrellin A, from Hypocrella bambusae, is a novel photosensitizer of high singlet oxygen quantum yield for photodynamic therapy (PDT). Tissue distributions were studied in tumor-bearing mice as a function of time following administration. The tumor model was S-180 sarcoma transplanted into one hind leg of male Kunming mice; hypocrellin A (HA) was delivered to the mice by intravenous injection of 5 mg/kg of body weight as a suspension either as a unilamellar liposome or in dimethyl sulfoxide (DMSO)-solubilized saline. The HA was isolated from several tissues and organs, as well as tumors and peritumoral muscles and skin. Quantitation was performed by a high-performance liquid chromatographic technique with detection that utilizes the native fluorescence of HA. Independent of the delivery system, the dye was retained in tumors at higher concentrations than in normal tissues, except for kidney, liver, lung and spleen. The dye retention in tumors was high and was vehicle dependent. For the liposomal system, the maximal accumulation in tumor and maximal ratios of dye in tumor versus peritumoral muscle and skin occurred 12 h postinjection; for the DMSO saline system, the maximal ratio occurred earlier, 6 h postadministration. Liposomal delivery improved the selective accumulation of the dye in tumor with higher maximal levels in tumor and higher ratios of tumor-to-muscle and tumor-to-skin. Levels of dye were very low or not detectable in the brain. The PDT efficacy of HA in the liposome and DMSO saline systems was determined by evaluating the tumor volume regression percent. The PDT efficacy of HA in liposomes was highest when light treatment was performed at 12 h postinjection, consistent with the highest retention of HA in tumors. Similarly, the maximal PDT efficacy in DMSO saline was attained at 6 h postinjection, the highest HA retention point in tumor. Moreover, the peak PDT efficacy of HA in liposomes was much higher than that of HA in DMSO saline and even hematoporphyrin monomethylether.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568169

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  12 in total

1.  Can nanotechnology potentiate photodynamic therapy?

Authors:  Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Hoon Chung; Anastasia Yaroslavsky; Maria Garcia-Diaz; Julie Chang; Long Y Chiang; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2012-03       Impact factor: 7.848

Review 2.  Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives.

Authors:  F S De Rosa; M V Bentley
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

Review 3.  Photonanomedicine: a convergence of photodynamic therapy and nanotechnology.

Authors:  Girgis Obaid; Mans Broekgaarden; Anne-Laure Bulin; Huang-Chiao Huang; Jerrin Kuriakose; Joyce Liu; Tayyaba Hasan
Journal:  Nanoscale       Date:  2016-06-20       Impact factor: 7.790

Review 4.  Liposomal formulations of photosensitizers.

Authors:  Sanjana Ghosh; Kevin A Carter; Jonathan F Lovell
Journal:  Biomaterials       Date:  2019-07-10       Impact factor: 12.479

5.  Photodynamic inhibitory effects of three perylenequinones on human colorectal carcinoma cell line and primate embryonic stem cell line.

Authors:  Lan Ma; Hong Tai; Cong Li; Yu Zhang; Ze-Hua Wang; Wei-Zhi Ji
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

Review 6.  Shining light on nanotechnology to help repair and regeneration.

Authors:  Asheesh Gupta; Pinar Avci; Magesh Sadasivam; Rakkiyappan Chandran; Nivaldo Parizotto; Daniela Vecchio; Wanessa C M A de Melo; Tianhong Dai; Long Y Chiang; Michael R Hamblin
Journal:  Biotechnol Adv       Date:  2012-08-21       Impact factor: 14.227

7.  Enhanced Production and Anticancer Properties of Photoactivated Perylenequinones.

Authors:  Zeinab Y Al Subeh; Huzefa A Raja; Susan Monro; Laura Flores-Bocanegra; Tamam El-Elimat; Cedric J Pearce; Sherri A McFarland; Nicholas H Oberlies
Journal:  J Nat Prod       Date:  2020-08-10       Impact factor: 4.050

Review 8.  Mechanisms for Tuning Engineered Nanomaterials to Enhance Radiation Therapy of Cancer.

Authors:  Sandhya Clement; Jared M Campbell; Wei Deng; Anna Guller; Saadia Nisar; Guozhen Liu; Brian C Wilson; Ewa M Goldys
Journal:  Adv Sci (Weinh)       Date:  2020-10-28       Impact factor: 16.806

9.  Photodynamic Therapy of the Murine LM3 Tumor Using Meso-Tetra (4-N,N,N-Trimethylanilinium) Porphine.

Authors:  L L Colombo; A Juarranz; M Cañete; A Villanueva; J C Stockert
Journal:  Int J Biomed Sci       Date:  2007-12

Review 10.  Drug Carrier for Photodynamic Cancer Therapy.

Authors:  Tilahun Ayane Debele; Sydney Peng; Hsieh-Chih Tsai
Journal:  Int J Mol Sci       Date:  2015-09-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.